Long-term follow-up of anti-infliximab antibodies in radiographic axial spondyloarthritis patients: a marker of drug survival and tapering.
Clarissa Q PimentelAna Cristina de Medeiros RibeiroAndrea Y ShimabucoPercival Degrava Sampaio-BarrosJúlio César B MoraesClaudia G SchainbergCelio Roberto GonçalvesElaine P LeonLéonard De Vinci K KupaSandra G PasotoNádia Emi AikawaClovis A SilvaEloisa S BonfaCarla Gonçalves Schahin SaadPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
TNFi good clinical response.